LONZA NLONZA NLONZA N

LONZA N

No trades
See on Supercharts
Market capitalization
‪39.74 B‬CHF
‪654.00 M‬CHF
‪6.72 B‬CHF
‪71.91 M‬
Beta (1Y)
2.12

About LONZA N

CEO
Albert M. Baehny
Headquarters
Basel
Website
Employees (FY)
‪18 K‬
Founded
1897
ISIN
CH0013841017
FIGI
BBG00HCYR1Y5
Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment offers small molecule drug substances and intermediates related services. The Cell and Gene segment includes the Cell and Gene Technologies and Bioscience businesses. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LONN is 534.0 CHF — it has decreased by 0.19% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange LONZA N stocks are traded under the ticker LONN.
LONZA N is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for LONZA N has a max estimate of 650.0 CHF and a min estimate of 375.0 CHF.
LONN earnings for the last quarter are 6.12 CHF whereas the estimation was 6.72 CHF which accounts for −8.86% surprise. Estimated earnings for the next quarter are 6.85 CHF. See more details about LONZA N earnings.
LONZA N revenue for the last quarter amounts to ‪3.08 B‬ CHF despite the estimated figure of ‪3.18 B‬ CHF. In the next quarter revenue is expected to reach ‪3.43 B‬ CHF.
Yes, you can track LONZA N financials in yearly and quarterly reports right on TradingView.
Like other stocks, LONN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LONZA N stock right from TradingView charts — choose your broker and connect to your account.
LONN reached its all-time high on Sep 7, 2021 with the price of 785.4 CHF, and its all-time low was 30.4 CHF and was reached on Jun 4, 2012.
See other stocks reaching their highest and lowest prices.
As of Apr 15, 2024, the company has ‪18.00 K‬ employees. See our rating of the largest employees — is LONZA N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LONZA N EBITDA is ‪1.93 B‬ CHF, and current EBITDA margin is 21.96%. See more stats in LONZA N financial statements.